FDA-Approved Labeling: Is Enough Enough?
The FDA Law Blog
AUGUST 21, 2023
Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts.
The FDA Law Blog
AUGUST 21, 2023
Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts.
The Checkup by Singlecare
JANUARY 30, 2024
Hailing from the selective serotonin-reuptake inhibitor ( SSRI ) class of drugs, citalopram is often used for the treatment of major depressive disorder or off-label use treating anxiety disorder. These communication efforts can make all the difference. For all the good work that it does, citalopram also has its downsides.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
FEBRUARY 27, 2023
Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. By Karla L. 829(e); and 2) the modified registration requirement for online pharmacies. 21 U.S.C. § 21 U.S.C. § 802(54)(D)(i).
The Checkup by Singlecare
OCTOBER 30, 2023
In addition, sertraline is prescribed for several other off-label indications, including binge eating disorder and body dysmorphic disorder, even sexual dysfunction conditions like premature ejaculation. Therefore, any onset of symptoms should be managed by immediate communication with a healthcare professional.
ISPE
MARCH 29, 2023
Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.
ISPE
MARCH 29, 2023
Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.
The Thyroid Pharmacist
JANUARY 6, 2023
It breaks my heart to think about the many thyroid patients who get labeled as clinically depressed instead of being tested for thyroid antibodies, and to think of the patients who start on thyroid hormones without consideration of dosage and form, resulting in ongoing symptoms, including depression.
Let's personalize your content